The current research shows that RAGE and its interaction with ligands increase the efficiency of antiapoptotic proteins while diminishing the effectiveness of proapoptotic proteins in promoting cancer cell proliferation, invasion, and angiogenesis. The gene discussed is PROS1; the disease is cancer.